HOME >> BIOLOGY >> NEWS
Mutation in a single gene switches a fungus-grass symbiosis from mutualistic to antagonistic

chlo festucae and its host, perennial ryegrass, Lolium perenne. As a result, they discovered a novel role for reactive oxygen species (ROS) in regulating the mutualistic interaction between E. festucae and its grass host.

Tanaka et al. used a forward genetics approach to create mutants of the endophyte that would be unable to establish or maintain a mutualistic relationship with perennial ryegrass. They inserted foreign DNA randomly into the genome of Epichlo festucae, resulting in a population of fungal strains having disruptions in different genes throughout the fungal genome. From this collection they isolated a mutant that is unable to synchronize its growth with that of the plant host.

Plants infected with the mutant fungus showed stunted growth, premature senescence, and death, whereas those infected with the wild-type fungus exhibited their usual growth pattern. This was accompanied by a dramatic increase in fungal endophyte growth within the plant compared with plants inoculated with wild-type fungus. The fungal hyphae of the wild type fungus showed limited branching and were mostly oriented parallel to the intercellular spaces of the leaf. On the other hand, the hyphae of the mutant fungus showed extensive colonization of the leaf--similar to a pathogenic infection. As a result, the biomass of the mutant fungus increased significantly compared to wild type. Thus a mutualistic interaction became an antagonistic one with the mutation of a single gene.

Tanaka et al. then went on identify and sequence the fungal gene responsible for the mutant phenotype. They determined that the foreign DNA had disrupted a fungal gene, called noxA, which encodes an enzyme that catalyzes the conversion of molecular oxygen to superoxide. The altered symbiotic phenotype is due to a mutation (caused by the insertion of a segment of foreign DNA) in the E. festucae noxA gene.

NADPH oxidase catalyzes the production of ROS or superoxides by tr
'"/>

Contact: Beatrice Grabowski
beatrice@aspb.org
301-251-0560
American Society of Plant Biologists
22-Mar-2006


Page: 1 2 3

Related biology news :

1. Mutation improves memory, may lead to memory-enhancing pill
2. Mutation in HNF4A associated with an increase in birthweight and macrosomia
3. Mutations point the way to new leukemia drugs
4. Mutation in tumor suppressor gene causes pancreatic islet cells to reproduce
5. Mutation in deafness gene can help heal wounds and prevent infection
6. Mutation in blood stem cells provides clues to cancer development
7. Mutation in brain cells of descendants of Abraham Lincoln suggest he suffered from movement disorder
8. Mutations in the BRAF gene predict sensitivity to a novel class of cancer drugs
9. Mutation may raise prostate-cancer risk in African Americans
10. Mutations in NOTCH1 gene cause aortic valve disease
11. Mutation in clams protects against paralytic shellfish poisoning but raises human health risk

Post Your Comments:
(Date:8/19/2015)... HAUPPAUGE, N.Y. , Aug. 19, 2015 /PRNewswire/ ... announced that it has entered into a Definitive ... intellectual property, of iris authentication market leader EyeLock ... transaction, VOXX will have a controlling interest in ... is subject to completion of due diligence.  Expanding ...
(Date:8/12/2015)... , Aug. 12, 2015   MedNet Solutions ... the entire spectrum of clinical research, is proud to ... the company,s comprehensive SaaS-based eClinical technology platform, has led ... the first two quarters of 2015.   Q2 2015 ... largest quarters measured by contract value sold in the ...
(Date:8/11/2015)... , August 11, 2015 Today, ZUK ... Already received as well as expected revenues in 2015 that relate ... FPC,s communicated revenue guidance of approximately 2,200 MSEK for 2015. ... is a prominent smartphone manufacturer in ... ZUK selected FPC1 155 for ...
Breaking Biology News(10 mins):VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5MedNet Solutions Experiences Explosive Corporate Growth 2FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2
(Date:8/26/2015)... ... August 26, 2015 , ... Lee ... in the development and manufacture of highly valued cardiac markers used in early ... extensive expertise with protein chemistry has led to the development and commercialization of ...
(Date:8/26/2015)... GERMANTOWN, Md. , Aug. 26, 2015 ... synthetic biology, announced today the closing of its previously ... in full by the underwriters of their option to ... the public offering price of $41.00 per share.  The ... of shares of common stock sold by Intrexon to ...
(Date:8/26/2015)... , August 26, 2015 After litigating ... Europlasma NV relating to P2i United States ... their dispute in the United States ... the part of either party. As a result of the ... of California dismissed the case without ...
(Date:8/26/2015)... ... 2015 , ... The 2015 Epigenomics & Metabolomics Meeting in Boston ... Asymmetrex to share the first report on progress with its crowdsourcing campaign designed ... tissue stem cells. , With a name like “H2A.Z asymmetry,” the new biomarker would ...
Breaking Biology Technology:Lee Biosolutions Announces Increased Investment in the Development and Manufacturing of Biomarkers Used in Early Detection Of Heart Disease 2Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 2Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 3Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 4P2i Settles United States Litigation 2Asymmetrex Reports Positive Indicators for Crowdsourcing Campaign to Evaluate New Biomarker for Counting Adult Tissue Stem Cells for the First Time 2Asymmetrex Reports Positive Indicators for Crowdsourcing Campaign to Evaluate New Biomarker for Counting Adult Tissue Stem Cells for the First Time 3Asymmetrex Reports Positive Indicators for Crowdsourcing Campaign to Evaluate New Biomarker for Counting Adult Tissue Stem Cells for the First Time 4
Cached News: